Q4 results: How LTTS, Cyient, Zensar Technologies and Laurus Labs fared in March quarter

During the quarter, LTTS signed one USD 100 million, one USD 30 million and two deals each of USD 20 million and USD 10 million. Additionally, they signed one significant empanelment agreement. LTTS shares were down by 1% at Rs 5180.95 on the BSE on Thursday.

Cyient

Cyient’s revenue was up nearly 2.5% YoY to Rs 612 crore for the Q4FY24 while net profit stood at Rs 115 crore , which grew by 3% from Rs 112 crore for the same period last year. The board has recommended a final dividend of Rs 18 per share. It had also declared an interim dividend of Rs 12 per share in October 2023.

Cyient closed at Rs 1,916, 1.3% higher on the BSE.

Laurus Labs

Laurus Labs reported a 26% YoY increase in PAT at Rs 76 crore, while their revenue stood at Rs 1,440 for Q4FY24, up 4% YoY.

EBITDA increased by 10% to Rs 259 crore while the EBITDA margin stood at 18%. The company has announced an interim dividend of Rs 0.40 per share.

Laurus Labs closed 2% lower at Rs 425.30 on the BSE on Thursday.

Zensar Technologies

Zensar’s Q4 revenue stood at Rs 1,230 crore up by 1.4% YoY while the PAT rose by 45.4% at Rs 177 crore. The EBITDA grew 15.5% to Rs 2013 crore. The board has recommended a final dividend of Rs 7 per share, subject to shareholder approval. The record date would be announced at a later date.

Zensar Technologies shares closed at Rs 575.20, down by 1% on the BSE.

Also read:

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)